Ogsiveo (nirogacestat) — Medica
Desmoid tumors (aggressive fibromatosis)
Initial criteria
- Patient is age ≥ 18 years
- According to the prescriber, the patient has progressing desmoid tumors (defined as ≥ 20% progression within 12 months)
- The desmoid tumors are not amenable to surgery or radiotherapy
- According to the prescriber, the patient requires systemic treatment
Approval duration
1 year